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Abstract
Objectives: Among the diverse forms of amyloidosis, secondary type is the most frequent one. Diagnosis of amy-
loid deposition is based on the identification of the fibrillary protein amyloid by means of Congo Red (CR) or crys-
tal violet (CV) stains, but these techniques do not differentiate between the different types of amyloid fibrils. The 
aim of this study was to identify by immunofluorescence (IF) AA amyloid a pathological fibrillar low-molecular-
weight protein formed by cleavage of serum amyloid A (SAA) protein in labial salivary gland (LSG) biopsies from 
patients with secondary amyloidosis. 
Study design: 98 LSG were studied, 65 were from patients with secondary amyloidosis and 33 from subjects with 
chronic inflammatory diseases without evidence of this anomaly. All sections were stained with hematoxylin and 
eosin (H&E), CV, CR and IF using anti-AA antibodies. Positive and negative controls were used for all techniques.
Results: CV and CR demonstrated that the amyloid substance was found mainly distributed periductally (93.8%), 
followed by periacinar and perivascular locations (p<0.001); however, the IF demonstrated that amyloid AA sub-
stance predominates in the periacinar area (73.8%), followed by periductal and perivascular locations (p<0.001). 
IF has a sensitivity of 83%, 100% of specificity, 100% of predictive positive value and 75% of predictive negative 
value.Conclusions: The results of this study confirm the efficacy of the LSG biopsy as a highly reliable method for 
diagnosis of secondary amyloidosis. 
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Introduction
Amyloidosis is a term used to describe a group of dis-
orders that share as a common feature the extra-cellular 
deposition of the insoluble fibrillary protein amyloid in 
diverse organs and tissues (1, 2). Amyloid appears as 
an eosinophilic substance which under the light micro-
scope has a hyaline appearance, and it exhibits a charac-
teristic apple-green birefringence in Congo red stained 
tissue sections when examined under polarized light 
(3-5). Electron microscopy has demonstrated a unique 
beta-pleated sheet configuration of these protein fibrils, 
which is now believed to be responsible for their typical 
staining properties (6).
The current classification of amyloidosis is based on 
the nature of the plasma proteins precursor which act as 
the source of the fibril deposits. These plasma proteins 
are diverse in nature and unrelated, but all may produce 
amyloid deposits with a common beta-fibrilar struc-
ture (7). According to the predominant type of amyloid 
protein there are two main forms of acquired systemic 
amyloidosis: AA or reactive (secondary) amyloidosis 
and AL (primary) amyloidosis. AA amyloidosis devel-
ops in patients with chronic inflammatory conditions in 
whom the fibril protein is derived from the circulating 
acute-phase lipoprotein known as serum amyloid A (8). 
AA amyloidosis is relatively infrequent in the western 
hemisphere (9), while its prevalence is higher in devel-
oping countries, where chronic infectious and inflam-
matory conditions are more frequent and severe.
The diagnosis of amyloidosis is based on a clinical sus-
picion and it is confirmed by a biopsy. The usual his-
tological methods for demonstrating amyloid in biopsy 
specimens are limited by the fact that only a few ana-
tomic sites can be submitted to this procedure due to the 
obvious problem of sampling within organs with this 
invasive method. While biopsies of the kidney, liver and 
spleen provide a high frequency of positive results, the 
procedure is not exempt of risks, such as bleeding. La-
bial salivary gland (LSG) biopsy has been proved as a 
safe and highly sensitive and reliable method for diag-
nosis of secondary amyloidosis (10-12); however, when 
positive result is obtained with any method, the type of 
amyloidosis has to be determined.
The aim of this study was to identify the amyloid pro-
tein AA by means of immunofluorescence method in 
biopsies of LSG from patients with previous diagnosis 
of amyloidosis, and to determine the sensitivity and 
specificity of this technique. 
Materials and Methods
98 LSG biopsies were studied, of which 65 (41 males 
and 24 females) belonged to patients with chronic in-
flammatory diseases and diagnosis of secondary amy-
loidosis, the range of age was 18 to 80 years (mean: 43.1 
years) and 33 LSG biopsies belonged to patients without 
amyloidosis but with chronic inflammatory diseases 
(19 men and 14 women), the range of age was 18 to 84 
years (mean: 44.5 years). Pulmonary or multi-systemic 
tuberculosis was the more frequent diagnosis (75.5%) 
and nephrotic syndrome was the salient clinical finding 
(71.4%). The salient clinical features of both groups of 
patients are shown in table 1.


Salientfeatures

WithAmyloidosis

WithoutAmyloidosis

Total

Underlyingdisease
Tuberculosis
Rheumatoidarthritis
Basalbronchiectasies
Others 

ClinicalFeatures
Nephroticsyndrome
Renalfailure
Others 


53 (81.5%)
0 (0.0%)
5 (7.7%)
7 (10.8%)


51 (78.5%)
14 (21.5%)
0 (0.0%)


21 (63.6%)
3 (9.1%)
1 (3.0%)
8 (24.3%)


19 (57.6%)
6 (18.2%)
8 (24.2%)


74 (75.5%)
3 (3.1%)
6 (6.1%)
15 (15.3%)


70 (71.4%)
20 (20.4%)
8 (8.2%)


Total

65 (100.0%)

33 (100.0%)

98 (100.0%)

Table 1. Clinical background of patients.
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Each specimen was fixed in buffered formalin and fur-
ther processed for conventional microscopy. Hematox-
ylin and eosin (H&E), crystal violet (CV), Congo red 
(CR) and immunofluorescence method using anti-AA 
amyloid antibody were systematically performed in all 
cases. Immunodetection of AA amyloid by anti-AA 
amyloid monoclonal antibody (DAKO, Carpinteria, CA) 
was performed using an indirect immunofluorescence 
method.  Positive and negative controls were used for 
all techniques. Kidney biopsies were used as control tis-
sue. Histomorphologic changes were recorded in H&E 
stained slides. The presence of amyloid was identified 
in CV, CR and immunofluorescence studied sections, 
and its distribution was recorded as periductal, peri-
acinar and perivascular location. For the analysis of the 
information was used descriptive statistics, chi-square 
test with significance level of p<0.05 to compare differ-
ent locations.  
Results
The metachromatic stains CV and CR demonstrated 
that the amyloid substance was found mainly distrib-
uted through the periductal area (93.8%), followed by 
periacinar (86.2%) and perivascular (32.3%) locations 
(p<0.001).  
In contrast, immunofluorescence demonstrated that 
amyloid substance AA was located mainly around 
acini (73.8%), followed by periductal (46.2%) and 
perivascular (40.0%) deposits, as shown in table 2 and 
Figures 1 and 2 (p<0.001).
In 54 of the 65 patients with amyloidosis associated to 
inflammatory conditions (83.1%), AA amyloid deposits 
were identified in LSG biopsies, producing a sensitivity 
of 83%. Immunofluorescence method has a sensitivity 
of 83%, specificity of 100%, predictive positive value of 
100% and 75% of predictive negative value.

Distribution Metachromaticstain Inmunofluorescence
Periductal
Periacinar
Perivascular 
61 (93.8%)
56 (86.2%)
21 (32.3%)
30 (46.2%)
48 (73.8%)
26 (40.0%)

Total

65 (100.0%)

54(83.1%)

Table 2. Distribution of amyloid deposits in patients with amyloidosis and positive labial salivary gland biopsies.
Fig. 1. The amyloid deposits in labial salivary gland (H&E, x 400).
Fig. 2. Immunostaining with anti-AA amyloid antibody reveals amy-
loid deposits around the acini and excretory duct in the center (im-
munofluorescence, x 400).
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Discussion
Secondary or reactive systemic (AA) amyloidosis oc-
curs in patients affected by a number of chronic inflam-
matory diseases in which the fibrillary proteins derived 
from the circulating acute-phase precursor lipoprotein 
known as serum amyloid A are deposited in diverse tis-
sues.
In this study, we determined the sensitivity and specifi-
city of CV, CR and immunofluorescence in the dem-
onstration of AA amyloid in LSG biopsies. Compared 
with studies that have used other tissues, our results, 
and those obtained by Delgado and Mosqueda (10) 
demonstrate that LSG biopsy is more sensitive to detect 
amyloid deposits, and is a valuable tool for detecting 
secondary amyloidosis. Hachulla et al (11) also have 
confirmed that LSG biopsy is a highly sensitive method 
for diagnosis of amyloidosis, as they found a sensitiv-
ity of 86%. The technical procedure is easy to perform 
by any physician, involves no discomfort for the patient 
and the results are reproducible.
Amyloid deposits in LSG usually appeared in a peri-
ductal distribution on CV or CR stained sections. These 
features were also found by Delgado and Mosqueda (10) 
and Hachulla et al (11). In the present study, the use of 
anti-AA antibody was helpful for confirmation of AA 
amyloidosis, particularly in cases with scant deposits of 
this substance. In addition, immunostaining with anti-
AA amyloid antibody revealed that amyloid deposits 
were found mainly around acini.
The distribution of AA amyloid was fairly constant 
within the LSG tissue in every case. Amyloid deposits 
were observed as perivascular deposits in only 50% of 
cases. Our observations suggest that amyloid deposits 
in LSG in cases of secondary amyloidosis probably oc-
cur around basement membranes, and perhaps some 
blood vessels are destroyed by the severe amyloid infil-
tration, which could explain the lower incidence in this 
location.
Furthermore, immunohistologic characterization with 
anti-AA antibodies demonstrated the presence of amy-
loid deposits and can confirm the findings obtained with 
CV or CR, thus avoiding false-positive or false-negative 
results. In this study, we have demonstrated that LSG 
biopsy studied with immunofluorescence is a highly 
sensitive method for the diagnosis of secondary amy-
loidosis.
References 
1. Bergesio F, Ciciani AM, Santostefano M, Brugnano R, Manganaro 
M, Palladini G, et al. Renal involvement in systemic amyloidosis--an 
Italian retrospective study on epidemiological and clinical data at 
diagnosis. Nephrol Dial Transplant. 2007;22:1608-18. 
2. Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N 
Engl J Med. 1997 ;337:898-909. 
3. Delgado WA, Arana-Chavez VE. Amyloid deposits in labial sa-
livary glands identified by electron microscopy. J Oral Pathol Med. 
1997;26:51-2. 
4. Lachmann HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin 
CA, Gillmore JD, et al. Natural history and outcome in systemic AA 
amyloidosis. N Engl J Med. 2007;356:2361-71. 
5. Dember LM. Amyloidosis-associated kidney disease. J Am Soc 
Nephrol. 2006 ;17:3458-71. 
6. Stone MJ. Amyloidosis: a final common pathway for protein depo-
sition in tissues. Blood. 1990;75:531-45. 
7. Hawkins PN, Lavender JP, Pepys MB. Evaluation of systemic 
amyloidosis by scintigraphy with 123I-labeled serum amyloid P 
component. N Engl J Med. 1990 ;323:508-13. 
8. Esteve V, Almirall J, Ponz E, García N, Ribera L, Larrosa M, et al. 
[Renal involvement in amyloidosis. Clinical outcomes, evolution and 
survival]. Nefrologia. 2006;26:212-7. 
9. Hawkins PN, Richardson S, Vigushin DM, David J, Kelsey CR, 
Gray RE, et al. Serum amyloid P component scintigraphy and tur-
nover studies for diagnosis and quantitative monitoring of AA 
amyloidosis in juvenile rheumatoid arthritis. Arthritis Rheum. 
1993;36:842-51. 
10. Delgado WA, Mosqueda A. A highly sensitive method for diag-
nosis of secondary amyloidosis by labial salivary gland biopsy. J 
Oral Pathol Med. 1989;18:310-4. 
11. Hachulla E, Janin A, Flipo RM, Saïle R, Facon T, Bataille D, et al. 
Labial salivary gland biopsy is a reliable test for the diagnosis of pri-
mary and secondary amyloidosis. A prospective clinical and immu-
nohistologic study in 59 patients. Arthritis Rheum. 1993;36:691-7. 
12. Ensari C, Ensari A, Tümer N, Ertug E. Clinicopathological and 
epidemiological analysis of amyloidosis in Turkish patients. Nephrol 
Dial Transplant. 2005;20:1721-5. 
